G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2013
11/26/2013	US8592170 High molecular weight Ngal as a biomarker for chronic kidney disease
11/26/2013	US8592169 Tumour marker proteins and uses thereof
11/26/2013	US8592168 Methods for diagnosing and treating neuroendocrine cancer
11/26/2013	US8592167 Enzyme detection device
11/26/2013	US8592166 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
11/26/2013	US8592165 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
11/26/2013	US8592164 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
11/26/2013	US8592163 Method of determining immune enhancement of virus infectivity using Fc receptor-transfected cell lines
11/26/2013	US8592161 Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
11/26/2013	US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013	US8592149 Methods and compositions for antibody therapy
11/26/2013	US8591904 Asymmetrically branched polymer conjugates and microarray assays
11/26/2013	US8591902 Antibody binding to lysophosphatidylglucoside, and composition comprising the same
11/26/2013	US8591832 Multi-channel wellplate filling system
11/26/2013	US8591827 Stack of test strips and method for the production thereof
11/26/2013	US8591816 Cartridge device for blood analysis
11/26/2013	US8591815 Measuring device and methods for use therewith
11/26/2013	US8591814 Sample plate for fluid analysis in a refinery process
11/26/2013	US8591813 Reaction cartridge, reaction apparatus and method of moving solution in reaction cartridge
11/26/2013	US8591809 Substrate transfer container, gas purge monitoring tool, and semiconductor manufacturing equipment with the same
11/26/2013	US8591436 Lancets for bodily fluid sampling supplied on a tape
11/26/2013	US8590364 Beverage disguise for hand held breathalyzer interface of ignition interlock device
11/26/2013	US8590363 Personal breathalyzer having digital circuitry
11/26/2013	CA2745998C Biomarkers for diagnosing alzheimer's disease
11/26/2013	CA2679188C System and method for operating an electrochemical analyte sensor
11/26/2013	CA2675316C Test vessel, test strip, test kit, and test method
11/26/2013	CA2644352C Systems and methods for characterizing wood furnish
11/26/2013	CA2618374C Trimeric collagen scaffold antibodies
11/26/2013	CA2573710C Electrochemical sensor for in-vivo or ex-vivio measurements of the carbon dioxide partial pressure of living tissue
11/26/2013	CA2535833C Method and apparatus for assay of electrochemical properties
11/26/2013	CA2532038C Compositions and methods for stable isotope labelling of biological compounds
11/26/2013	CA2469472C Endothelial stem cells, populations, methods of isolation and use thereof
11/26/2013	CA2457918C Mullerian inhibiting substance levels and ovarian response
11/26/2013	CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013	CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies
11/26/2013	CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/26/2013	CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013	CA2417986C Single-labeled oligonucleotide probes
11/26/2013	CA2335240C Cyanine dyes and synthesis methods thereof
11/25/2013	DE202012010319U1 Vorrichtung zur Analyse eines Anteils an Fremdstoffen in, vorzugsweise mineralölbasierten, flüssigen Stoffen Apparatus for analyzing a portion of foreign substances in, preferably mineral oil-based liquid substances
11/25/2013	CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method
11/21/2013	WO2013173756A1 A method for quantifying proteins and isoforms thereof
11/21/2013	WO2013173699A2 METHOD FOR DETECTION OF PrP-INTERACTING Aβ OLIGOMERIC SPECIES IN BIOLOGICAL MATERIALS AS A DIAGNOSIS OF ALZHEIMER'S DISEASE
11/21/2013	WO2013173685A1 Gelc-ms using stain free technology
11/21/2013	WO2013173642A1 High-throughput lipidomics
11/21/2013	WO2013173596A1 Chronic traumatic encephalopathy in blast-exposed individuals
11/21/2013	WO2013173590A1 Vaccines for hsv-2
11/21/2013	WO2013173582A1 Hepatitis c virus neutralizing antibody
11/21/2013	WO2013173546A1 Surrogate addition device and method of analyte concentration
11/21/2013	WO2013173525A1 Clinical diagnostic systems
11/21/2013	WO2013173517A1 Stroma biomarkers for the diagnosis of prostate cancer
11/21/2013	WO2013173499A2 Diagnostic methods and devices for monitoring chronic glycemia
11/21/2013	WO2013173497A1 Systems and methods for detecting molecular interactions using magnetic beads
11/21/2013	WO2013173493A1 Non-invasive method of diagnosing renal fibrosis
11/21/2013	WO2013173485A1 Detection of bladder cancers
11/21/2013	WO2013173480A1 Detection of bladder cancer recurrence
11/21/2013	WO2013173478A1 Screening assay for bladder cancer
11/21/2013	WO2013173472A1 Methods of assessing chromosomal instabilities
11/21/2013	WO2013173466A1 Methods for inactivation and extraction of acid-fast bacteria for characterization and/or identification using mass spectrometry
11/21/2013	WO2013173463A1 Erg/tff3/hmwck triple immunostain for detection of prostate cancer
11/21/2013	WO2013173454A1 Phosphatidylinositol-3-kinase c2 beta modulators and methods of use thereof
11/21/2013	WO2013173401A1 Process for measuring liquid property and use thereof
11/21/2013	WO2013173400A1 Device for measuring liquid property and use thereof
11/21/2013	WO2013173384A1 Method and system for sorting biological samples
11/21/2013	WO2013173348A1 Cross-reactive antibodies against dengue virus and uses thereof
11/21/2013	WO2013173312A1 Using modulators of ccr5 for treating cancer
11/21/2013	WO2013173281A1 Quantitative methods and kits for providing reproducible ihc4 scores
11/21/2013	WO2013173266A1 Methods for identifying patterns of ifn induced expression and use in diagnosis, monitoring and therapy
11/21/2013	WO2013173031A1 Cell-surface signatures for isolating neurons from cell cultures derived from pluripotent stem cells
11/21/2013	WO2013172955A1 Tumor cell isolation/purification process and methods for use thereof
11/21/2013	WO2013172947A1 Method and system for predicting recurrence and non-recurrence of melanoma using sentinel lymph node biomarkers
11/21/2013	WO2013172926A1 Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
11/21/2013	WO2013172920A1 Systems and methods for automated biomass sampling and analysis
11/21/2013	WO2013172873A2 Method and apparatus for analyzing acetone in breath
11/21/2013	WO2013172868A1 Methods and apparatus for measuring the total organic content of aqueous streams
11/21/2013	WO2013172866A2 Sensors for detection of mesothelin
11/21/2013	WO2013172779A2 Method for indicating the presence or non-presence of prostate cancer
11/21/2013	WO2013172631A1 Sample analyzing chip
11/21/2013	WO2013172579A1 Nanoprobe, and method for detecting target material using same
11/21/2013	WO2013172544A1 Novel two-photon absorbing fluorescent substance, and substrate sensing method using same
11/21/2013	WO2013172421A1 Ampk protein activator screening method, and ampk protein activator
11/21/2013	WO2013172379A1 Novel antibody and application thereof
11/21/2013	WO2013172347A1 Method for detecting iga aggregate, and method for testing iga nephropathy
11/21/2013	WO2013172344A1 Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity c-reactive protein
11/21/2013	WO2013172306A1 Decelerator damage state notification device, mechanical system with decelerator damage state notification function, and medium on which decelerator damage state notification program is recorded
11/21/2013	WO2013172265A1 Cancer cell-trapping metal filter, cancer cell-trapping metal filter sheet, cancer cell-trapping device, and manufacturing methods therefor
11/21/2013	WO2013172105A1 Marker for detecting pancreatic cancer
11/21/2013	WO2013171890A1 Hatching egg inspection device
11/21/2013	WO2013171777A2 Use of trop-2 as predictive marker of response to anti-tumor therapy based on inhibitors of cd9, akt and molecules of the tetraspanin signalling network
11/21/2013	WO2013171696A1 Method for identifying ligands of the ahr receptor having therapeutic sebosuppressive activity, and said ligands
11/21/2013	WO2013171673A1 New diagnostic metodology for pancreatic neoplasia
11/21/2013	WO2013171667A1 Device and method for the determination and monitoring of water toxicity
11/21/2013	WO2013171655A1 An in vitro method for diagnosing of endometriosis
11/21/2013	WO2013171586A2 Metabolite biomarkers for staging colorectal cancer
11/21/2013	WO2013171568A1 Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and lc/ms/ms workflow
11/21/2013	WO2013171508A1 Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma
11/21/2013	WO2013171490A1 Method for determining the amount of an analyte by mass spectrometry with the\|help of specially designed deuterated analyte analogs
11/21/2013	WO2013171489A1 Methods to predict progression of berret ' s esophagus to high grade dysplasia esophageal adenocarcinoma
11/21/2013	WO2013171446A2 Saliva testing
11/21/2013	WO2013171296A1 Diagnostic and treatment of sarcoidosis

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 3937